Paris, France

Valérie Fontaine

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Paris, FR (2019)
  • Cachan, FR (2023)

Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Valérie Fontaine: Innovator in Retinal Disease Treatment

Introduction

Valérie Fontaine is a prominent inventor based in Paris, France. He has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal diseases. With a total of 2 patents, Fontaine's work is paving the way for innovative therapeutic solutions.

Latest Patents

Fontaine's latest patents include a method utilizing mirabegron for the treatment of retinal diseases. This method specifically addresses age-related macular degeneration, offering a novel approach to managing this condition. Additionally, he has developed a pharmaceutical composition that includes norbixin, aimed at protecting cells of the retinal pigment epithelium in mammals. This composition is derived from the purification of seeds, showcasing Fontaine's commitment to utilizing natural resources in medical advancements.

Career Highlights

Throughout his career, Fontaine has worked with notable organizations such as Biophytis and Sorbonne Université. His experience in these institutions has allowed him to refine his expertise and contribute to groundbreaking research in retinal health.

Collaborations

Fontaine has collaborated with esteemed colleagues, including Jose-Alain Sahel and René Lafont. These partnerships have further enriched his research and development efforts in the field of ophthalmology.

Conclusion

Valérie Fontaine's innovative work in the treatment of retinal diseases exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations highlight the importance of continued research and development in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…